Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-21-042835
Filing Date
2021-08-10
Accepted
2021-08-09 21:41:41
Documents
95
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A emma-10ka_20201231.htm   iXBRL 10-K/A 4694929
2 EX-23.1 emma-ex231_332.htm EX-23.1 4365
3 EX-31.1 emma-ex311_12.htm EX-31.1 15847
4 EX-31.2 emma-ex312_9.htm EX-31.2 15732
5 EX-32.1 emma-ex321_8.htm EX-32.1 7658
6 GRAPHIC ghljaw5dx1fd000001.jpg GRAPHIC 124029
  Complete submission text file 0001564590-21-042835.txt   18780105

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA emma-20201231.xsd EX-101.SCH 91374
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE emma-20201231_cal.xml EX-101.CAL 88770
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE emma-20201231_def.xml EX-101.DEF 381326
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE emma-20201231_lab.xml EX-101.LAB 716807
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE emma-20201231_pre.xml EX-101.PRE 610096
12 EXTRACTED XBRL INSTANCE DOCUMENT emma-10ka_20201231_htm.xml XML 4434632
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

EIN.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35527 | Film No.: 211158184
SIC: 2834 Pharmaceutical Preparations